The Claim
In monocytes isolated from pregnant women with preeclampsia, in vitro exposure to progesterone or vitamin D is associated with reduced expression of NLRP1 and NLRP3 inflammasome components, TLR4, MyD88, and NF-κB, as well as lower levels of the inflammatory cytokines IL-1β, IL-18, and TNF-α.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
When scientists test immune cells from pregnant women with a condition called preeclampsia, adding progesterone or vitamin D to the cells in a lab seems to calm down their inflammation. It’s like turning down the volume on the body’s alarm system.
See the scientific wording
In monocytes isolated from pregnant women with preeclampsia, exposure to progesterone or vitamin D in vitro is associated with reduced expression of NLRP1 and NLRP3 inflammasome components, TLR4, MyD88, and NF-κB, as well as lower levels of inflammatory cytokines IL-1β, IL-18, and TNF-α, suggesting these hormones may modulate sterile inflammation at the cellular level.
What the research says
1 studyScientists found that giving progesterone and vitamin D to immune cells from women with preeclampsia calmed down their inflammation, just like the claim said. These hormones helped reduce the signals that cause swelling and damage in the body.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.